MILANI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 375
AS - Asia 87
EU - Europa 28
SA - Sud America 3
AF - Africa 2
Totale 495
Nazione #
US - Stati Uniti d'America 373
CN - Cina 67
IT - Italia 15
KR - Corea 8
GB - Regno Unito 3
IN - India 3
TW - Taiwan 3
BR - Brasile 2
CA - Canada 2
FR - Francia 2
ID - Indonesia 2
MK - Macedonia 2
PL - Polonia 2
VN - Vietnam 2
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DE - Germania 1
FI - Finlandia 1
HK - Hong Kong 1
KH - Cambogia 1
NG - Nigeria 1
ZA - Sudafrica 1
Totale 495
Città #
Simi Valley 43
Ashburn 10
Fairfield 10
Guangzhou 10
Beijing 8
Wilmington 8
Hangzhou 7
Houston 7
Seattle 7
Woodbridge 7
Cambridge 6
Santa Cruz 6
Shenyang 6
Buffalo 5
University Park 5
Ann Arbor 4
Changsha 4
San Diego 4
Chicago 3
Chongqing 3
Redmond 3
Shanghai 3
Xian 3
Bengaluru 2
Dong Ket 2
Hebei 2
Jinan 2
Nanchang 2
Nanjing 2
Pisa 2
Seoul 2
Sunnyvale 2
Taipei 2
Warsaw 2
Arcadia 1
Burnaby 1
Changchun 1
Chengdu 1
Clearwater 1
Dallas 1
Durham 1
Harbin 1
Helsinki 1
Kicevo 1
Mountain View 1
Muizenberg 1
Ottawa 1
Phoenix 1
Piacenza 1
Port Harcourt 1
Recife 1
Rivoli 1
Rome 1
San Jose 1
San Mateo 1
Skopje 1
Torino 1
Turin 1
Weehawken 1
Wuhan 1
Zhengzhou 1
Ürümqi 1
Totale 222
Nome #
Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions, file e27ce429-ba9f-2581-e053-d805fe0acbaa 508
Buparlisib , an oral pan-PI3K inhibitor for the treatment of breast cancer, file e27ce432-5e86-2581-e053-d805fe0acbaa 1
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society, file e61348dc-dc5a-4282-8e44-1333c59647d7 1
Totale 510
Categoria #
all - tutte 683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201934 0 0 0 0 0 0 0 0 0 0 19 15
2019/202091 16 12 14 15 9 6 2 4 4 3 1 5
2020/202161 3 5 2 6 1 5 5 10 4 12 2 6
2021/202259 7 3 5 6 7 3 5 2 2 7 6 6
2022/202318 1 2 6 4 1 0 1 1 1 0 1 0
2023/202414 2 0 5 0 1 1 1 1 0 2 1 0
Totale 510